LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2025 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular First Quarter 2025 Financial Results Conference Call. [Operator Instructions]. I would like to turn the call over to Mr.
Lemaitre Vascular Inc (LMAT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ranger Investment Management Conrad Doenges (Cio) | 522,509 | $43,838,505 | -21% | 3.13% |
| 2. | Millennium Management Israel Englander | 211,222 | $17,721,526 | +120% | 0.01% |
| 3. | Renaissance Technologies Jim Simons | 154,300 | $12,945,770 | -6% | 0.02% |
| 4. | Driehaus Capital Richard Driehaus | 154,006 | $12,921,103 | -42% | 0.12% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 125,974 | $10,569,223 | +217% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.06 | 30 | Director | 181 | 2020-08-26 | Filing | |
| $25.28 | 151 | Director | 151 | 2020-05-21 | Filing | |
| $28.35 | 7,074 | Officer, Director | 43,557 | 2020-08-14 | Filing | |
| $5.50 | 4,000 | Large Shareholder, Officer, Director | 3,927,163 | 2012-06-08 | Filing | |
| $5.34 | 2,000 | Large Shareholder, Officer, Director | 3,917,163 | 2012-05-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $84.69 | 1,099 | Officer, Director | 1,827,003 | 2025-05-20 | Filing | |
| $85.24 | 3,300 | Officer, Director | 1,828,102 | 2025-05-20 | Filing | |
| $84.94 | 5,700 | Officer, Director | 1,796,783 | 2025-05-19 | Filing | |
| $85.86 | 71,168 | Officer, Director | 1,802,483 | 2025-05-19 | Filing | |
| $84.77 | 18,733 | Officer, Director | 1,873,651 | 2025-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,590,803 | $301,268,377 | 0.01% | |
| 2. | 1,641,273 | $137,702,823 | 2.08% | |
| 3. | 1,581,106 | $132,654,795 | 0% | |
| 4. | 1,078,723 | $90,504,930 | 1.81% | |
| 5. | 863,749 | $72,468,505 | 1.35% |
News See All
Jim Cramer Recently Talked About These 15 Stocks
On Tuesday, Jim Cramer, host of Mad Money, offered his perspective on the day’s market rally as he delved into the impact of the ongoing dynamic between President Donald Trump and Federal Reserve Chair...
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2024 Earnings Call Transcript February 27, 2025LeMaitre Vascular, Inc. reports earnings inline with expectations.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2024 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q3 2024 Financial Results Conference Call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. J.J.
LeMaitre Vascular (LMAT) Surged Due to Robust Global Markets
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Small Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Robust Quarterly Result Lifted LeMaitre Vascular (LMAT) in Q2
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2024 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q2 2024 Financial Results Conference Call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. J.J.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen. Welcome to the LeMaitre Vascular First Quarter 2024 Financial Results Conference Call. As a reminder, today’s call is being recorded.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36. LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2023 Earnings Call Transcript
Operator: Welcome to the LeMaitre Vascular Q3 2023 Financial Results Conference Call. After the speaker’s presentation, there will be a question-and-answer session.
Billionaire Hedge Funds
